Evidence map›Paper›PMID 36460000›Full record

ArticleStem cell reports2022

Simultaneous isolation of proximal and distal lung progenitor cells from individual mice using a 3D printed guide reduces proximal cell contamination of distal lung epithelial cell isolations.

Hani N Alsafadi, John Stegmayr, Victoria Ptasinski, Iran Silva, Margareta Mittendorfer, Lynne A Murray, Darcy E Wagner

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 4 countries.

Hani N AlsafadiDepartment of Experimental Medical Sciences, Faculty of Medicine, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Faculty of Medicine, Lund University, Lund, Sweden; Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.
John StegmayrDepartment of Experimental Medical Sciences, Faculty of Medicine, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Faculty of Medicine, Lund University, Lund, Sweden; Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.
Victoria PtasinskiDepartment of Experimental Medical Sciences, Faculty of Medicine, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Faculty of Medicine, Lund University, Lund, Sweden; Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Iran SilvaDepartment of Experimental Medical Sciences, Faculty of Medicine, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Faculty of Medicine, Lund University, Lund, Sweden; Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.
Margareta MittendorferDepartment of Experimental Medical Sciences, Faculty of Medicine, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Faculty of Medicine, Lund University, Lund, Sweden; Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.
Lynne A MurrayResearch and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Darcy E WagnerDepartment of Experimental Medical Sciences, Faculty of Medicine, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Faculty of Medicine, Lund University, Lund, Sweden; Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden; NanoLund, Lund University, Lund, Sweden. Electronic address: darcy.wagner@med.lu.se.
Lund University · SEAstraZeneca (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The respiratory epithelium consists of multiple, functionally distinct cell types and is maintained by regionally specific progenitor populations that repair the epithelium following injury. Several in vitro methods exist for studying lung epithelial repair using primary murine lung cells, but isolation methods are hampered by a lack of surface markers distinguishing epithelial progenitors along the respiratory epithelium. Here, we developed a 3D printed lobe divider (3DLD) to aid in simultaneous isolation of proximal versus distal lung epithelial progenitors from individual mice that give rise to differentiated epithelia in multiple in vitro assays. In contrast to 3DLD-isolated distal progenitor cells, commonly used manual tracheal ligation methods followed by lobe removal resulted in co-isolation of rare proximal cells with distal cells, which altered the transcriptional landscape and size distribution of distal organoids. The 3DLD aids in reproducible isolation of distal versus proximal progenitor populations and minimizes the potential for contaminating populations to confound in vitro assays.

Indexed as

Epithelial CellsStem CellsAnimalsCell DifferentiationCell SeparationLungMicePrinting, Three-Dimensional3D printingair-liquid interfacecell isolationlung epitheliumlung progenitorsmurine alveolar type II cellsmurine tracheal epithelial cellsorganoidsRNA-seq deconvolutionsurgical guide

Identifiers

PMID36460000
PMCPMC9768627
OpenAlexW4310496404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.